Riskpilot← Back to searchSign inGet full accessANKERLØKKA LEGESENTER DA
DAActiveOrg 995185415Kråkerøyveien 9, 1671 KråkerøyGeneral medical practice activities · NACE 8621Est. 20100 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -11K
+79% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK -11K | +79% |
| Total assets | NOK 344K | +14% |
| Equity | NOK 344K | +14% |
| Employees | 0 | — |
Legal name
ANKERLØKKA LEGESENTER DA
Org number
995185415
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
10. mars 2010
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Deltakerne i fellesskap.
Company purpose
Legevirksomhet.
Address
Kråkerøyveien 9, 1671 Kråkerøy
Phone
+4769339620
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 466 | 2 719 | 0 | 0 | 0 |
| Staff expenses | −1 292 | −1 197 | −0 | −0 | −0 |
| EBITDA | −179 | 140 | −60 | −40 | 0 |
| Depreciation & amort. | −21 | −68 | −30 | −14 | −12 |
| EBIT | −200 | 72 | −91 | −54 | −12 |
| Net financials | 0 | −1 | 0 | 0 | 0 |
| Profit before tax | −200 | 71 | −91 | −54 | −11 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −200 | 71 | −91 | −54 | −11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 588 | 587 | 357 | 302 | 344 |
| Equity | 330 | 401 | 356 | 302 | 344 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 258 | 185 | 1 | 0 | 0 |
| Total debt | 258 | 185 | 1 | 0 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20202024
Net profit margin
-1113800.0%
This company
8.1%
Market median
-13750717% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2010 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 0% | 0% | 2018 | |
| Company | 0% | 0% | 2018 | |
| Individual | 0% | 0% | 2018 | |
| Individual | 0% | 0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ANKERLØKKA LEGESENTER DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Kase-Berg | Chief Executive Officer | 0 companies |